Does Quinolone- or Macrolide-Resistant <i>Streptococcus agalactiae</i> Bacteremia Affect Patient Outcome? A Multicenter Cohort Study

The prevalence of quinolone- and macrolide-resistant Group B Streptococcus (GBS) is increasing worldwide, but the relationship between resistance GBS to these antibiotics patient outcome remains unclear. Therefore, we evaluated whether blood stream infection caused by or associated with high mortality. Our findings in 77 patients bacteremia demonstrate that quinolone macrolide may not be risk factors for 30-day